Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
Xiao‐Ming Meng(Chinese University of Hong Kong, Shenzhen), Hui Y. Lan(Chinese University of Hong Kong, Shenzhen)
Cited by 99
Related Papers
TGF-β/Smad signaling in renal fibrosis
|Frontiers in Physiology|2015|648
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
|Diabetologia|2013|353
The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
|Diabetes|2010|224
NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation
|Laboratory Investigation|2017|202